Full-Time

Inside Sales Representative

Posted on 11/19/2024

Element Biosciences

Element Biosciences

201-500 employees

Next-generation sequencing technology provider

Biotechnology
Healthcare

Compensation Overview

$85k - $97kAnnually

+ Stock Options + Sales Commission

Junior, Mid

California, USA + 2 more

More locations: Texas, USA | San Diego, CA, USA

San Diego onsite preferred; open to candidates from Texas and Bay Area.

Category
Inside Sales
Sales & Account Management
Required Skills
Salesforce
Requirements
  • Bachelor’s degree is required, in Biology/Molecular Biology/Genetics or a related field of study – Advanced Degrees are a plus
  • Life Sciences industry experience with 1-3 years of cold-calling experience, work in CRMs, or sequencing laboratory experience
  • Must be a self-starter with the ability to mentor more junior ISR colleagues
  • Experience with strategic selling/Professional Selling Skills (PSS), working with multiple cross functional teams, and value-based selling
  • 1-3 years of experience in prospecting, lead qualification, funnel management, drive to close and ongoing account management
  • Candidate must be comfortable with conducting presentations effectively and professionally to customers/peers/management
Responsibilities
  • Meet and/or surpass sales targets for instrument sales, sequencing consumables, and related services at the time of new capital purchase(s) and through the lifetime of the instrument
  • Manage the customer sales process through phone, e-mail, web/remote conferencing, and limited on-site visits to promote and further develop Element business
  • Work with other commercial teams to prospect and qualify sales leads from a wide variety of sources, to identify the owner of these qualified opportunities, and to route these in Salesforce to the appropriate sales lead
  • Achieve and/or exceed all sales and leads targets assigned by commercial leadership
  • Effectively manage all inbound/outbound communication with customers
  • This includes but is not limited to: lead qualification from events, marketing campaigns and prospecting customer lists; coordinating with internal resources (field sales, field application scientists, product management, commercial leadership) to address customer questions and objections; identifying potential upsell/cross-sell opportunities, and driving increased instrument utilization through the life of the product
  • Establish and maintain a strong, positive, and productive relationship with customers and individuals within the organization
  • Maintain the Salesforce CRM database for accurate lead qualification, funnel management and forecasting in a timely and complete manner, while maximizing productivity during key selling time
  • Achieve daily customer phone contact objectives to deliver sales presentations to address customer’s research needs and increase opportunities and sales

Element Biosciences specializes in next-generation sequencing (NGS) technology, primarily through its product, the AVITI System. This compact benchtop system provides high-quality DNA sequencing at a low cost, charging only $1 per million reads, which is significantly less than the industry average. The AVITI System is designed to deliver industry-leading accuracy, allowing users, including academic researchers and pharmaceutical companies, to maximize their resources. Element Biosciences differentiates itself from competitors by offering a cost-effective solution and establishing partnerships with other biotech firms, such as QIAGEN, to provide complete NGS workflows. Additionally, the company runs the 2023 AVITI for All Grant program, which offers free sequencing for various applications, further promoting research and demonstrating the AVITI System's capabilities. The goal of Element Biosciences is to make high-quality sequencing accessible and affordable for a wide range of users.

Company Stage

Series D

Total Funding

$659.5M

Headquarters

San Diego, California

Founded

2017

Growth & Insights
Headcount

6 month growth

10%

1 year growth

17%

2 year growth

28%
Simplify Jobs

Simplify's Take

What believers are saying

  • Element Biosciences' recent $277M Series D funding round underscores strong investor confidence and provides substantial resources for growth and innovation.
  • The rapid growth in AVITI System installations, from 20 to over 150 units in a year, indicates strong market adoption and customer satisfaction.
  • The introduction of AVITI24 and Trinity platforms positions Element Biosciences at the forefront of multi-omics and targeted sequencing, potentially revolutionizing research capabilities.

What critics are saying

  • The competitive landscape in NGS technology is intense, with established players potentially overshadowing Element Biosciences' market presence.
  • Rapid expansion and scaling may strain operational capabilities and affect product quality or customer support.

What makes Element Biosciences unique

  • Element Biosciences offers the AVITI System, which provides high-quality sequencing at a significantly lower cost than industry standards, making advanced sequencing more accessible.
  • Strategic partnerships with companies like QIAGEN and Twist Bioscience enhance the AVITI System's capabilities, offering comprehensive NGS workflows and exome sequencing solutions.
  • The company's grant program, AVITI for All, democratizes access to sequencing technology, showcasing the system's capabilities and fostering innovation across various fields.

Help us improve and share your feedback! Did you find this helpful?

Benefits

100% company-paid medical, dental, & vision coverage

Flexible spending & health savings accounts

Premier mental health care

401(k) with immediately vested 4% company match

Company-paid Life and AD&D insurance

Stock option grants

Flexible time off

10 paid annual holidays

8-weeks paid parental leave